US HB2115 | 2019-2020 | 116th Congress

Status

Spectrum: Slight Partisan Bill (Democrat 4-2)
Status: Engrossed on October 29 2019 - 50% progression
Action: 2019-10-29 - Received in the Senate and Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Engrossed) [PDF]

Summary

Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act This bill requires the Centers for Medicare & Medicaid Services (CMS) to publish certain payment information regarding pharmacy benefit managers (PBMs) and prescription drugs. Specifically, the CMS must publish certain information, as reported by PBMs, relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies, in accordance with specified confidentiality requirements. The bill also provides statutory authority for certain provisions of the CMS rule titled "Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses," published on May 23, 2019. The rule requires, in part, Medicare prescription drug plan sponsors to implement an electronic, real-time benefit tool that is capable of integrating with at least one prescriber's electronic prescribing system or electronic health record. The tool must provide prescribers with patient-specific, real-time formulary and benefit information, including information regarding cost-sharing, formulary alternatives, and utilization management requirements. The rule takes effect January 1, 2021.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act

Sponsors


Roll Calls

2019-10-28 - House - On motion to suspend the rules and pass the bill, as amended RC# 586 (Y: 403 N: 0 NV: 28 Abs: 0) [PASS]

History

DateChamberAction
2019-10-29SenateReceived in the Senate and Read twice and referred to the Committee on Finance.
2019-10-28HouseThe title of the measure was amended. Agreed to without objection.
2019-10-28HouseMotion to reconsider laid on the table Agreed to without objection.
2019-10-28HouseOn motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 403 - 0 (Roll no. 586). (text: CR H8516)
2019-10-28HouseConsidered as unfinished business. (consideration: CR H8520-8521)
2019-10-28HouseAt the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
2019-10-28HouseDEBATE - The House proceeded with forty minutes of debate on H.R. 2115.
2019-10-28HouseConsidered under suspension of the rules. (consideration: CR H8516-8519)
2019-10-28HouseMs. Schakowsky moved to suspend the rules and pass the bill, as amended.
2019-05-21HouseSubcommittee Hearings Held.
2019-04-09HouseReferred to the Subcommittee on Health.
2019-04-08HouseReferred to the Subcommittee on Health.
2019-04-08HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-04-08HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-04-08HouseIntroduced in House

Same As/Similar To

HB2113 (Related) 2019-04-09 - Ordered to be Reported by Voice Vote.
HB2296 (Related) 2019-09-24 - Placed on the Union Calendar, Calendar No. 170.
HB3408 (Related) 2019-06-24 - Referred to the Subcommittee on Health.
HB3415 (Related) 2019-06-24 - Referred to the Subcommittee on Health.
HB19 (Related) 2019-12-19 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
SB3129 (Related) 2019-12-19 - Read twice and referred to the Committee on Finance.

Subjects


US Congress State Sources


Bill Comments

feedback